Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 1/2007

01-01-2007 | Focus on....

Imaging atherosclerosis in the vulnerable patient

Author: Giovanni Lucignani

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 1/2007

Login to get access

Excerpt

Atherosclerotic disease results in several million deaths annually. Identification of high-risk atherosclerotic lesions prone to rupture and thrombosis may greatly decrease the morbidity and mortality associated with atherosclerosis. A consensus document from the Screening for Heart Attack Prevention and Education (SHAPE) Task Force [1, 2] concludes the following: (1) All types of atherosclerotic plaques with a high likelihood of thrombotic complications and rapid progression should be considered as vulnerable plaques. (2) Vulnerable plaques are not the only culprit factors in the development of acute coronary syndromes, infarction and cardiac death. Vulnerable blood (prone to thrombosis) and vulnerable myocardium (prone to fatal arrhythmia) play an important role in the outcome. Therefore, the term “vulnerable patient” may be more appropriate to identify subjects with a high likelihood of developing cardiac events in the near future. (3) A method for cumulative risk assessment of vulnerable patients needs to be developed that may include variables based on plaque, blood and myocardial vulnerability. …
Literature
1.
go back to reference Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003;108:1664–72.PubMedCrossRef Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003;108:1664–72.PubMedCrossRef
2.
go back to reference Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003;108:1772–8.PubMedCrossRef Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003;108:1772–8.PubMedCrossRef
3.
go back to reference Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, et al. From vulnerable plaque to vulnerable patient – Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol 2006;98 (2A):2H–15H3.PubMedCrossRef Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, et al. From vulnerable plaque to vulnerable patient – Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol 2006;98 (2A):2H–15H3.PubMedCrossRef
4.
go back to reference Budoff MJ, Gopal A, Gopalakrishnan D. Cardiac computed tomography: diagnostic utility and integration in clinical practice. Clin Cardiol 2006;29(9 Suppl 1):I4–I14. Budoff MJ, Gopal A, Gopalakrishnan D. Cardiac computed tomography: diagnostic utility and integration in clinical practice. Clin Cardiol 2006;29(9 Suppl 1):I4–I14.
5.
6.
go back to reference Ben-Haim S, Israel O. PET/CT for atherosclerotic plaque imaging. Q J Nucl Med Mol Imaging 2006;50(1):53–60.PubMed Ben-Haim S, Israel O. PET/CT for atherosclerotic plaque imaging. Q J Nucl Med Mol Imaging 2006;50(1):53–60.PubMed
7.
go back to reference Davies JR, Rudd JH, Weissberg PL, Narula J. Radionuclide imaging for the detection of inflammation in vulnerable plaques. J Am Coll Cardiol 2006;47(8 Suppl):C57–C68.PubMedCrossRef Davies JR, Rudd JH, Weissberg PL, Narula J. Radionuclide imaging for the detection of inflammation in vulnerable plaques. J Am Coll Cardiol 2006;47(8 Suppl):C57–C68.PubMedCrossRef
8.
go back to reference Purushothaman KR, Sanz J, Zias E, Fuster V, Moreno PR. Atherosclerosis neovascularization and imaging. Curr Mol Med 2006;6(5):549–56.PubMedCrossRef Purushothaman KR, Sanz J, Zias E, Fuster V, Moreno PR. Atherosclerosis neovascularization and imaging. Curr Mol Med 2006;6(5):549–56.PubMedCrossRef
9.
go back to reference Sirol M, Fuster V, Fayad ZA. Plaque imaging and characterization using magnetic resonance imaging: towards molecular assessment. Curr Mol Med 2006;6(5):541–8.PubMedCrossRef Sirol M, Fuster V, Fayad ZA. Plaque imaging and characterization using magnetic resonance imaging: towards molecular assessment. Curr Mol Med 2006;6(5):541–8.PubMedCrossRef
10.
go back to reference Elmaleh DR, Fischman AJ, Tawakol A, Zhu A, Shoup TM, Hoffmann U, et al. Detection of inflamed atherosclerotic lesions with diadenosine-5′,5‴-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography. Proc Natl Acad Sci USA 2006;Oct 12; [Epub ahead of print]. Elmaleh DR, Fischman AJ, Tawakol A, Zhu A, Shoup TM, Hoffmann U, et al. Detection of inflamed atherosclerotic lesions with diadenosine-5′,5‴-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography. Proc Natl Acad Sci USA 2006;Oct 12; [Epub ahead of print].
11.
go back to reference Isobe S, Tsimikas S, Zhou J, Fujimoto S, Sarai M, Branks MJ, et al. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5. J Nucl Med 2006;47(9):1497–1505.PubMed Isobe S, Tsimikas S, Zhou J, Fujimoto S, Sarai M, Branks MJ, et al. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5. J Nucl Med 2006;47(9):1497–1505.PubMed
12.
go back to reference Nahrendorf M, Jaffer FA, Kelly KA, Sosnovik DE, Aikawa E, Libby P, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006;114:1504–11.PubMedCrossRef Nahrendorf M, Jaffer FA, Kelly KA, Sosnovik DE, Aikawa E, Libby P, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006;114:1504–11.PubMedCrossRef
13.
go back to reference Tang T, Howarth SP, Miller SR, Trivedi R, Graves MJ, King-Im JU, et al. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 2006;37:2266–70.PubMedCrossRef Tang T, Howarth SP, Miller SR, Trivedi R, Graves MJ, King-Im JU, et al. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 2006;37:2266–70.PubMedCrossRef
14.
go back to reference Fujii K, Mintz GS, Carlier SG, Costa JR Jr, Kimura M, Sano K, et al. Intravascular ultrasound profile analysis of ruptured coronary plaques. Am J Cardiol 2006;98:429–35.PubMedCrossRef Fujii K, Mintz GS, Carlier SG, Costa JR Jr, Kimura M, Sano K, et al. Intravascular ultrasound profile analysis of ruptured coronary plaques. Am J Cardiol 2006;98:429–35.PubMedCrossRef
Metadata
Title
Imaging atherosclerosis in the vulnerable patient
Author
Giovanni Lucignani
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 1/2007
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-006-0301-5

Other articles of this Issue 1/2007

European Journal of Nuclear Medicine and Molecular Imaging 1/2007 Go to the issue